Clinical Trials Logo

Osteoradionecrosis clinical trials

View clinical trials related to Osteoradionecrosis.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05412849 Recruiting - Clinical trials for Head and Neck Neoplasms

Radiation Field, Dose and Fractionation Related to Mandibular Complications

Start date: January 1, 2022
Phase:
Study type: Observational

Radiotherapy is inhibiting the healing capacity of the mandibular bone. Late complications as bone exposure, fracture of the jaw, osteoradionecrosis might be a consequence of this vulnerability. A factor that could be involved in the development of complications is field of radiation. There are limited number of studies investigating this relation. Retrospective analysis of a head and neck oncology register with prospectively included patients will be performed. Patients will be related to the University hospitals in Lund, Umea, Orebro, Stockholm. A thorough analysis of the medical journals in this group of patients will be performed. Included patients have been treated with combination of surgery and radiotherapy to treat malignancies in the head and neck region. At least 12 months follow up period is needed for inclusion. The scientific aim is to investigate weather the field of radiation and fractionation is crucial for developing the formentioned complications.

NCT ID: NCT04934644 Recruiting - Osteoradionecrosis Clinical Trials

The Effect of Hyperbaric Oxygen Treatment in Patients With Osteoradionecrosis.

ORN
Start date: March 19, 2019
Phase: N/A
Study type: Interventional

Osteoradionecrosis (ORN) is a severe delayed radiation-induced injury that can occur in patients whom have been subjected to radiotherapy for head and neck cancer. Hyperbaric oxygen treatment (HBO) is one treatment option. In Sweden it is used in some locations in combination to standard treatment which includes for example antibiotics, pain medication and surgery. There is still not sufficient evidence that this treatment is effective in this group of patients. The primary aim of this study will be to evaluate HBO as a treatment for osteoradionecrosis in terms of slowing the progression of the disease, or at the best, cure the disease.

NCT ID: NCT04826445 Recruiting - Clinical trials for Mandibular Osteoradionecrosis

USE OF 18FDG PET-CT TO PREDICT THE RESPONSE OF MANDIBULAR OSTEORADIONECROSIS TO THE PENTOCLO PROTOCOL WITH DOCUMENTED ANTIBIOTHERAPY

PENTOTEP
Start date: June 11, 2019
Phase:
Study type: Observational

This study is created in order to refine and reduce the duration between the medical and surgical therapeutic sequences (when the surgery is necessary) in these fragile patients knowing that conventional radiological changes can only be observed with a delay comprised between 3 and 6 months starting from observed clinical changes.

NCT ID: NCT04265430 Recruiting - Osteoradionecrosis Clinical Trials

Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors

Start date: September 17, 2018
Phase: Phase 4
Study type: Interventional

This phase IV trial studies how well serial magnetic resonance imaging (MRI) after radiation therapy works in predicting radiation-induced changes in the normal tissue of patients with oral cavity or skull base tumors. Performing MRIs after radiation therapy for patients with oral cavity or skull base tumors may help to predict osteoradionecrosis (a change in non-cancerous tissue).

NCT ID: NCT03905005 Recruiting - Surgery Clinical Trials

Jaw Reconstruction With Printed Titanium and Free Tissue Transfer

JaW PrinT
Start date: March 12, 2018
Phase:
Study type: Observational

JaW PrinT is a prospective observational cohort study evaluating the effectiveness of two different techniques of mandibular reconstruction.

NCT ID: NCT03145077 Recruiting - Clinical trials for Head and Neck Cancer

Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body

Start date: March 21, 2017
Phase: N/A
Study type: Interventional

This trial studies how well dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) works in diagnosing osteoradionecrosis in patients with head and neck cancer that is primary, has come back, or has spread to other places in the body who are undergoing radiation therapy. DCE-MRI may help doctors to predict osteoradionecrosis in patient with head and neck cancer undergoing radiation therapy.

NCT ID: NCT02661139 Recruiting - Clinical trials for Head and Neck Cancer

Prospective Registry of Prosthodontic Rehabilitation in Oncology Patients Undergoing Jaw Reconstruction

O-BRIDGE
Start date: June 2013
Phase:
Study type: Observational [Patient Registry]

The investigators aim to develop a prospective database in which patient demographics, surgical, dental, prosthetic and QOL parameters collected during consecutive visits within the framework of routine practice, are being registered for each oncological patient eligible for (immediate/delayed) fixed prosthodontic rehabilitation at time of oral cavity reconstruction

NCT ID: NCT00760682 Recruiting - Osteoradionecrosis Clinical Trials

Hyperbaric Oxygen Treatment of Mandibular Osteoradionecrosis. A Randomized Clinical Study

Start date: June 2008
Phase: Phase 2
Study type: Interventional

There is currently not sufficient evidence that hyperbaric oxygen (HBO) benefits the surgical removal of necrotic bone in osteoradionecrosis patients. This study aims at testing the hypothesis that HBO does improve healing after surgical removal of necrotic bone in irradiated previous head and neck cancer patients compared to not receiving HBO.